150 related articles for article (PubMed ID: 21331156)
1. Platelet-Derived Growth Factors in Non-GIST Soft-Tissue Sarcomas Identify a Subgroup of Patients with Wide Resection Margins and Poor Disease-Specific Survival.
Kilvaer TK; Valkov A; Sorbye SW; Donnem T; Smeland E; Bremnes RM; Busund LT
Sarcoma; 2010; 2010():751304. PubMed ID: 21331156
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
Kilvaer TK; Valkov A; Sorbye SW; Smeland E; Bremnes RM; Busund LT; Donnem T
J Transl Med; 2011 Jul; 9():104. PubMed ID: 21733164
[TBL] [Abstract][Full Text] [Related]
3. Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
Kilvaer TK; Valkov A; Sorbye S; Smeland E; Bremnes RM; Busund LT; Donnem T
PLoS One; 2010 Dec; 5(12):e15368. PubMed ID: 21179485
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor and progesterone receptor are prognostic factors in soft tissue sarcomas.
Valkov A; Sorbye S; Kilvaer TK; Donnem T; Smeland E; Bremnes RM; Busund LT
Int J Oncol; 2011 Apr; 38(4):1031-40. PubMed ID: 21271213
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
Ann Oncol; 2010 Feb; 21(2):223-231. PubMed ID: 19628565
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.
Valkov A; Sorbye SW; Kilvaer TK; Donnem T; Smeland E; Bremnes RM; Busund LT
PLoS One; 2011 Mar; 6(3):e17507. PubMed ID: 21390241
[TBL] [Abstract][Full Text] [Related]
9. The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.
Kilvaer TK; Smeland E; Valkov A; Sorbye SW; Bremnes RM; Busund LT; Donnem T
BMC Clin Pathol; 2014 Jan; 14(1):5. PubMed ID: 24444363
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
Brahmi M; Lesluyes T; Dufresne A; Toulmonde M; Italiano A; Mir O; Le Cesne A; Valentin T; Chevreau C; Bonvalot S; Penel N; Coindre JM; Le Guellec S; Le Loarer F; Karanian M; Blay JY; Chibon F
ESMO Open; 2021 Feb; 6(1):100037. PubMed ID: 33524869
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impacts of hypoxic markers in soft tissue sarcoma.
Smeland E; Kilvaer TK; Sorbye S; Valkov A; Andersen S; Bremnes RM; Busund LT; Donnem T
Sarcoma; 2012; 2012():541650. PubMed ID: 22454562
[TBL] [Abstract][Full Text] [Related]
12. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence.
Nordby Y; Richardsen E; Rakaee M; Ness N; Donnem T; Patel HR; Busund LT; Bremnes RM; Andersen S
Sci Rep; 2017 Feb; 7():43378. PubMed ID: 28233816
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of lymphocytes in soft tissue sarcomas.
Sorbye SW; Kilvaer T; Valkov A; Donnem T; Smeland E; Al-Shibli K; Bremnes RM; Busund LT
PLoS One; 2011 Jan; 6(1):e14611. PubMed ID: 21298041
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factors and receptors in Canine Lymphoma.
Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
[TBL] [Abstract][Full Text] [Related]
17. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.
Karvinen H; Rutanen J; Leppänen O; Lach R; Levonen AL; Eriksson U; Ylä-Herttuala S
Eur J Clin Invest; 2009 Apr; 39(4):320-7. PubMed ID: 19292888
[TBL] [Abstract][Full Text] [Related]
18. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
19. PDGF-D, a new protease-activated growth factor.
LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation.
Yu J; Deuel TF; Kim HR
J Biol Chem; 2000 Jun; 275(25):19076-82. PubMed ID: 10777515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]